MFDS
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
🇰🇷 Vanrafia in South Korea
Vanrafia (ATRASENTAN) regulatory status in South Korea.
Marketing authorisation
Vanrafia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Vanrafia approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Vanrafia in South Korea?
NOVARTIS holds the South Korean marketing authorisation.